Effects of β‐blockers on all‐cause mortality in patients with type 2 diabetes and coronary heart disease

AIMS: To assess whether the use of beta‐blockers influences mortality and the incidence of major cardiovascular events in patients with diabetes and coronary heart disease (CHD). MATERIALS AND METHODS: Using data from the Bypass Angioplasty Revascularization Investigation 2 Diabetes trial, we perfor...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsujimoto, Tetsuro, Sugiyama, Takehiro, Kajio, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2017
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5484336/
https://www.ncbi.nlm.nih.gov/pubmed/28094466
http://dx.doi.org/10.1111/dom.12878

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5484336/
https://www.ncbi.nlm.nih.gov/pubmed/28094466
http://dx.doi.org/10.1111/dom.12878

Ejemplares similares